Urecholine
Indicated for urinary retention, utilized to target bladder muscle receptors and support enhanced emptying in post-operative or neurogenic conditions.
Strengths: 25mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Cholinergic Agonist
- Pharmacological class
Parasympathomimetic
- Contraindications
asthma; epilepsy; peptic ulcer; coronary artery disease
- Precautions and warnings
monitor cardiac function; watch for symptoms of hypotension
- Minor side effects
salivation; flushing
- Moderate side effects
abdominal cramps; diarrhoea; bradycardia
- Serious side effects
bronchospasm — requires immediate medical attention
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Onset Time
30–90 minutes
- Duration
6 hours
- Storage instructions
Store at controlled room temperature.
- Drug interactions
ganglionic blocking agents
- Age restrictions
Not typically used in children.
- Pregnancy and breastfeeding
Pregnancy: Use with caution. Breastfeeding: No data available.
Patient summary
Indicated for urinary retention, utilized to target bladder muscle receptors and support enhanced emptying in post-operative or neurogenic conditions.
Mechanism of action
Bethanechol is a muscarinic cholinergic agonist. It mimics the action of acetylcholine, stimulating the contraction of the bladder detrusor muscle, which facilitates emptying in conditions of urinary retention.
Urecholine
Indicated for urinary retention, utilized to target bladder muscle receptors and support enhanced emptying in post-operative or neurogenic conditions.
Editorial Notes
- Active ingredient(s): Bethanechol
- Listed indication(s): Urinary Retention
Available option
- 60 tablets - 25 mg1535-25-mg-17931